Five Year Oncological Outcome After Complete Mesocolic Excision for Right-sided Colon Cancer: a Population-based Cohort Study View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2008-2019

ABSTRACT

Study based on existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III right-sided colon cancer. Detailed Description Population-based cohort study, predominantly prospective based, on the same population as the investigator's previously study comparing short-term outcome after CME with conventional colon resections. The COMES database combines the prospectively registered colon cancer database in Hillerød (CME data), and data from the national database of the Danish Colorectal Cancer Group (DCCG) covering patients undergoing conventional resection (non-CME) in the other three centers. The medical records of all the patients in the non-CME group (control group) were reviewed by colorectal surgeons from Hillerød. Data audit for all CME patients was performed by various co-authors employed at the other centers. A similar audit of data for non-CME patients having postoperative complications or recurrence was performed by the co-author representing the department treating the specific patients. Statistical analysis plan Continuous data are presented as median and interquartile ranges, and categorical data as frequencies and proportions. Kruskal-Wallis test and Fisher's exact test were used as appropriate. Death is a competing risk to recurrence and time-to-event analyses were performed as competing risk analyses obtaining the cumulative incidences for recurrence or death using the "cmprsk" R-package. Unbiased estimation of marginal or population-averaged treatment effects in observational and non-randomized studies can be obtained through different propensity score methods. Inverse Probability of Treatment Weighting (IPTW) uses the propensity score to weight each patient's data based on the inverse probability of receiving the treatment actually received. IPTW gives unbiased estimates of average treatment effects in time-to-event analyses if no differences in observed baseline covariates exist between the treatment groups. To account for baseline differences between patients in the two groups, stabilized weights truncated at the 0.99 interval were calculated using the "IPW" R-package. The following baseline covariates will be used: age, sex, ASA score, neoadjuvant chemotherapy, tumor location, tumor morphology, perineural invasion, extramural venous invasion, tumor stage, and serosal invasion. All covariates used and UICC stage, two-way interactions, and squared terms of continuous covariates will be assessed for balance between the CME and the non-CME group after IPTW using the "cobalt" R-package. Absolute mean differences in mean (using standardized mean difference) and proportions (using raw mean difference) below 0.1, variance ratios between 0.5 and 2, and Kolmogorov-Smirnov tests equal or below 0.05 will be accepted. Graphical inspection of the distribution of covariates will be also performed. The cause-specific hazards and overall survival will be analyzed using Cox regression. Binary outcomes will be analyzed using logistic regression. Lymph node yield will be analyzed using linear regression after logarithmic transformation. Number of metastatic lymph nodes will be analyzed using negative binominal regression. All analyses of primary and secondary outcomes will be performed after IPTW. The 95% confidence intervals for the estimates from the original Cox regression IPTW analyses will be constructed after 1000 bootstraps with replacement, and a robust sandwich estimator will be used for the logistic regression analyses in order to ensure correct variance estimation. All available data will be used. Model assumptions will be checked. A p-value below or equal to 0.05 will be considered significant. All analyses will be performed using R statistical software, version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria). More... »

URL

https://clinicaltrials.gov/show/NCT03754075

Related SciGraph Publications

  • 2014-07. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer in INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "description": "Study based on existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III right-sided colon cancer.\n\nDetailed Description\nPopulation-based cohort study, predominantly prospective based, on the same population as the investigator's previously study comparing short-term outcome after CME with conventional colon resections. The COMES database combines the prospectively registered colon cancer database in Hiller\u00f8d (CME data), and data from the national database of the Danish Colorectal Cancer Group (DCCG) covering patients undergoing conventional resection (non-CME) in the other three centers. The medical records of all the patients in the non-CME group (control group) were reviewed by colorectal surgeons from Hiller\u00f8d. Data audit for all CME patients was performed by various co-authors employed at the other centers. A similar audit of data for non-CME patients having postoperative complications or recurrence was performed by the co-author representing the department treating the specific patients. Statistical analysis plan Continuous data are presented as median and interquartile ranges, and categorical data as frequencies and proportions. Kruskal-Wallis test and Fisher's exact test were used as appropriate. Death is a competing risk to recurrence and time-to-event analyses were performed as competing risk analyses obtaining the cumulative incidences for recurrence or death using the \"cmprsk\" R-package. Unbiased estimation of marginal or population-averaged treatment effects in observational and non-randomized studies can be obtained through different propensity score methods. Inverse Probability of Treatment Weighting (IPTW) uses the propensity score to weight each patient's data based on the inverse probability of receiving the treatment actually received. IPTW gives unbiased estimates of average treatment effects in time-to-event analyses if no differences in observed baseline covariates exist between the treatment groups. To account for baseline differences between patients in the two groups, stabilized weights truncated at the 0.99 interval were calculated using the \"IPW\" R-package. The following baseline covariates will be used: age, sex, ASA score, neoadjuvant chemotherapy, tumor location, tumor morphology, perineural invasion, extramural venous invasion, tumor stage, and serosal invasion. All covariates used and UICC stage, two-way interactions, and squared terms of continuous covariates will be assessed for balance between the CME and the non-CME group after IPTW using the \"cobalt\" R-package. Absolute mean differences in mean (using standardized mean difference) and proportions (using raw mean difference) below 0.1, variance ratios between 0.5 and 2, and Kolmogorov-Smirnov tests equal or below 0.05 will be accepted. Graphical inspection of the distribution of covariates will be also performed. The cause-specific hazards and overall survival will be analyzed using Cox regression. Binary outcomes will be analyzed using logistic regression. Lymph node yield will be analyzed using linear regression after logarithmic transformation. Number of metastatic lymph nodes will be analyzed using negative binominal regression. All analyses of primary and secondary outcomes will be performed after IPTW. The 95% confidence intervals for the estimates from the original Cox regression IPTW analyses will be constructed after 1000 bootstraps with replacement, and a robust sandwich estimator will be used for the logistic regression analyses in order to ensure correct variance estimation. All available data will be used. Model assumptions will be checked. A p-value below or equal to 0.05 will be considered significant. All analyses will be performed using R statistical software, version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria).", 
        "endDate": "2019-03-01T00:00:00Z", 
        "id": "sg:clinicaltrial.NCT03754075", 
        "keywords": [
          "variance estimation", 
          "risk analysis", 
          "database", 
          "randomized study", 
          "medical record", 
          "patient", 
          "excision", 
          "average treatment effect", 
          "treatment group", 
          "sex", 
          "propensity score method", 
          "regression", 
          "lymph node", 
          "statistical software", 
          "Colonic Neoplasm", 
          "covariates", 
          "risk", 
          "tumor stage", 
          "distribution", 
          "logistic regression analysis", 
          "postoperative complication", 
          "version", 
          "stage", 
          "propensity score", 
          "foundation", 
          "linear model", 
          "Recurrence", 
          "nonparametric statistic", 
          "inspection", 
          "available data", 
          "variance", 
          "baseline difference", 
          "overall survival", 
          "baseline covariates", 
          "mean difference", 
          "short-term outcome", 
          "replacement", 
          "hazard", 
          "specific patient", 
          "estimation", 
          "p-values", 
          "death", 
          "national database", 
          "proportion", 
          "surgeon", 
          "neoadjuvant chemotherapy", 
          "Vienna", 
          "primary and secondary outcome", 
          "score", 
          "transformation", 
          "mean", 
          "same population", 
          "co-authors", 
          "model assumption", 
          "bootstrap", 
          "invasion", 
          "audit", 
          "age", 
          "cumulative incidence", 
          "categorical data", 
          "Austria", 
          "binary outcome", 
          "probability", 
          "frequency", 
          "Logistic Model", 
          "weight", 
          "perineural invasion", 
          "R package", 
          "difference", 
          "Fisher's", 
          "CME", 
          "confidence interval", 
          "estimator", 
          "Cox regression", 
          "statistical analysis", 
          "control group", 
          "two-way interaction", 
          "tumor location", 
          "time-to-event", 
          "interval", 
          "tumor morphology", 
          "population-based cohort study", 
          "balance", 
          "resection", 
          "treatment effect"
        ], 
        "name": "Five Year Oncological Outcome After Complete Mesocolic Excision for Right-sided Colon Cancer: a Population-based Cohort Study", 
        "sameAs": [
          "https://app.dimensions.ai/details/clinical_trial/NCT03754075"
        ], 
        "sdDataset": "clinical_trials", 
        "sdDatePublished": "2019-03-07T15:28", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "file:///pack/app/us_ct_data_00029.json", 
        "sponsor": [
          {
            "id": "https://www.grid.ac/institutes/grid.476266.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411905.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.414092.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411900.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411702.1", 
            "type": "Organization"
          }
        ], 
        "startDate": "2008-06-01T00:00:00Z", 
        "subjectOf": [
          {
            "id": "sg:pub.10.1007/s00384-014-1885-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000426524", 
              "https://doi.org/10.1007/s00384-014-1885-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1007/dcr.0b013e3181f433e3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005911352"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/sim.6607", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016759381"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1463-1318.2011.02896.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024138554"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/00273171.2011.568786", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1026060254"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/bjs.10083", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1034559406"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/j.1463-1318.2008.01735.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037600296"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1111/codi.13159", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049444969"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s1470-2045(14)71168-4", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050134132"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.suronc.2018.05.031", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1104266538"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "type": "MedicalStudy", 
        "url": "https://clinicaltrials.gov/show/NCT03754075"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03754075'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03754075'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03754075'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03754075'


     

    This table displays all metadata directly associated to this object as RDF triples.

    143 TRIPLES      16 PREDICATES      114 URIs      94 LITERALS      1 BLANK NODES

    Subject Predicate Object
    1 sg:clinicaltrial.NCT03754075 schema:about anzsrc-for:3142
    2 schema:description Study based on existing databases investigating the causal oncological treatment effects of complete mesocolic excision on UICC stage I-III right-sided colon cancer. Detailed Description Population-based cohort study, predominantly prospective based, on the same population as the investigator's previously study comparing short-term outcome after CME with conventional colon resections. The COMES database combines the prospectively registered colon cancer database in Hillerød (CME data), and data from the national database of the Danish Colorectal Cancer Group (DCCG) covering patients undergoing conventional resection (non-CME) in the other three centers. The medical records of all the patients in the non-CME group (control group) were reviewed by colorectal surgeons from Hillerød. Data audit for all CME patients was performed by various co-authors employed at the other centers. A similar audit of data for non-CME patients having postoperative complications or recurrence was performed by the co-author representing the department treating the specific patients. Statistical analysis plan Continuous data are presented as median and interquartile ranges, and categorical data as frequencies and proportions. Kruskal-Wallis test and Fisher's exact test were used as appropriate. Death is a competing risk to recurrence and time-to-event analyses were performed as competing risk analyses obtaining the cumulative incidences for recurrence or death using the "cmprsk" R-package. Unbiased estimation of marginal or population-averaged treatment effects in observational and non-randomized studies can be obtained through different propensity score methods. Inverse Probability of Treatment Weighting (IPTW) uses the propensity score to weight each patient's data based on the inverse probability of receiving the treatment actually received. IPTW gives unbiased estimates of average treatment effects in time-to-event analyses if no differences in observed baseline covariates exist between the treatment groups. To account for baseline differences between patients in the two groups, stabilized weights truncated at the 0.99 interval were calculated using the "IPW" R-package. The following baseline covariates will be used: age, sex, ASA score, neoadjuvant chemotherapy, tumor location, tumor morphology, perineural invasion, extramural venous invasion, tumor stage, and serosal invasion. All covariates used and UICC stage, two-way interactions, and squared terms of continuous covariates will be assessed for balance between the CME and the non-CME group after IPTW using the "cobalt" R-package. Absolute mean differences in mean (using standardized mean difference) and proportions (using raw mean difference) below 0.1, variance ratios between 0.5 and 2, and Kolmogorov-Smirnov tests equal or below 0.05 will be accepted. Graphical inspection of the distribution of covariates will be also performed. The cause-specific hazards and overall survival will be analyzed using Cox regression. Binary outcomes will be analyzed using logistic regression. Lymph node yield will be analyzed using linear regression after logarithmic transformation. Number of metastatic lymph nodes will be analyzed using negative binominal regression. All analyses of primary and secondary outcomes will be performed after IPTW. The 95% confidence intervals for the estimates from the original Cox regression IPTW analyses will be constructed after 1000 bootstraps with replacement, and a robust sandwich estimator will be used for the logistic regression analyses in order to ensure correct variance estimation. All available data will be used. Model assumptions will be checked. A p-value below or equal to 0.05 will be considered significant. All analyses will be performed using R statistical software, version 3.5.1 (R Foundation for Statistical Computing, Vienna, Austria).
    3 schema:endDate 2019-03-01T00:00:00Z
    4 schema:keywords Austria
    5 CME
    6 Colonic Neoplasm
    7 Cox regression
    8 Fisher's
    9 Logistic Model
    10 R package
    11 Recurrence
    12 Vienna
    13 age
    14 audit
    15 available data
    16 average treatment effect
    17 balance
    18 baseline covariates
    19 baseline difference
    20 binary outcome
    21 bootstrap
    22 categorical data
    23 co-authors
    24 confidence interval
    25 control group
    26 covariates
    27 cumulative incidence
    28 database
    29 death
    30 difference
    31 distribution
    32 estimation
    33 estimator
    34 excision
    35 foundation
    36 frequency
    37 hazard
    38 inspection
    39 interval
    40 invasion
    41 linear model
    42 logistic regression analysis
    43 lymph node
    44 mean
    45 mean difference
    46 medical record
    47 model assumption
    48 national database
    49 neoadjuvant chemotherapy
    50 nonparametric statistic
    51 overall survival
    52 p-values
    53 patient
    54 perineural invasion
    55 population-based cohort study
    56 postoperative complication
    57 primary and secondary outcome
    58 probability
    59 propensity score
    60 propensity score method
    61 proportion
    62 randomized study
    63 regression
    64 replacement
    65 resection
    66 risk
    67 risk analysis
    68 same population
    69 score
    70 sex
    71 short-term outcome
    72 specific patient
    73 stage
    74 statistical analysis
    75 statistical software
    76 surgeon
    77 time-to-event
    78 transformation
    79 treatment effect
    80 treatment group
    81 tumor location
    82 tumor morphology
    83 tumor stage
    84 two-way interaction
    85 variance
    86 variance estimation
    87 version
    88 weight
    89 schema:name Five Year Oncological Outcome After Complete Mesocolic Excision for Right-sided Colon Cancer: a Population-based Cohort Study
    90 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03754075
    91 schema:sdDatePublished 2019-03-07T15:28
    92 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    93 schema:sdPublisher Nb3099c22b35e489099b07813c79cec15
    94 schema:sponsor https://www.grid.ac/institutes/grid.411702.1
    95 https://www.grid.ac/institutes/grid.411900.d
    96 https://www.grid.ac/institutes/grid.411905.8
    97 https://www.grid.ac/institutes/grid.414092.a
    98 https://www.grid.ac/institutes/grid.476266.7
    99 schema:startDate 2008-06-01T00:00:00Z
    100 schema:subjectOf sg:pub.10.1007/s00384-014-1885-z
    101 https://doi.org/10.1002/bjs.10083
    102 https://doi.org/10.1002/sim.6607
    103 https://doi.org/10.1007/dcr.0b013e3181f433e3
    104 https://doi.org/10.1016/j.suronc.2018.05.031
    105 https://doi.org/10.1016/s1470-2045(14)71168-4
    106 https://doi.org/10.1080/00273171.2011.568786
    107 https://doi.org/10.1111/codi.13159
    108 https://doi.org/10.1111/j.1463-1318.2008.01735.x
    109 https://doi.org/10.1111/j.1463-1318.2011.02896.x
    110 schema:url https://clinicaltrials.gov/show/NCT03754075
    111 sgo:license sg:explorer/license/
    112 sgo:sdDataset clinical_trials
    113 rdf:type schema:MedicalStudy
    114 Nb3099c22b35e489099b07813c79cec15 schema:name Springer Nature - SN SciGraph project
    115 rdf:type schema:Organization
    116 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
    117 rdf:type schema:DefinedTerm
    118 sg:pub.10.1007/s00384-014-1885-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1000426524
    119 https://doi.org/10.1007/s00384-014-1885-z
    120 rdf:type schema:CreativeWork
    121 https://doi.org/10.1002/bjs.10083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034559406
    122 rdf:type schema:CreativeWork
    123 https://doi.org/10.1002/sim.6607 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016759381
    124 rdf:type schema:CreativeWork
    125 https://doi.org/10.1007/dcr.0b013e3181f433e3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005911352
    126 rdf:type schema:CreativeWork
    127 https://doi.org/10.1016/j.suronc.2018.05.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104266538
    128 rdf:type schema:CreativeWork
    129 https://doi.org/10.1016/s1470-2045(14)71168-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050134132
    130 rdf:type schema:CreativeWork
    131 https://doi.org/10.1080/00273171.2011.568786 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026060254
    132 rdf:type schema:CreativeWork
    133 https://doi.org/10.1111/codi.13159 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049444969
    134 rdf:type schema:CreativeWork
    135 https://doi.org/10.1111/j.1463-1318.2008.01735.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1037600296
    136 rdf:type schema:CreativeWork
    137 https://doi.org/10.1111/j.1463-1318.2011.02896.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1024138554
    138 rdf:type schema:CreativeWork
    139 https://www.grid.ac/institutes/grid.411702.1 schema:Organization
    140 https://www.grid.ac/institutes/grid.411900.d schema:Organization
    141 https://www.grid.ac/institutes/grid.411905.8 schema:Organization
    142 https://www.grid.ac/institutes/grid.414092.a schema:Organization
    143 https://www.grid.ac/institutes/grid.476266.7 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...